Stocks and Investing Stocks and Investing
Thu, December 21, 2017
Wed, December 20, 2017

Gena Wang Initiated (BCRX) at Hold and Held Target at $6 on, Dec 20th, 2017


Published on 2024-10-26 01:37:47 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold and Held Target at $6 on, Dec 20th, 2017.

Gena has made no other calls on BCRX in the last 4 months.



There are 3 other peers that have a rating on BCRX. Out of the 3 peers that are also analyzing BCRX, 1 agrees with Gena's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $6 on, Friday, September 15th, 2017


These are the ratings of the 2 analyists that currently disagree with Gena


  • Jessica Fye of "JP Morgan" Upgraded from Hold to Buy on, Wednesday, September 6th, 2017
  • Maury Raycroft of "Jefferies" Upgraded from Hold to Strong Buy on, Wednesday, September 6th, 2017

Contributing Sources